Literature DB >> 9393795

Protection against Pneumocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses.

B A Garvy1, J A Wiley, F Gigliotti, A G Harmsen.   

Abstract

To determine whether different antibody isotypes associated with T helper 1 (Th1) or Th2 responses are protective against Pneumocystis carinii, mice with disrupted interleukin 4 genes (IL-4(-/-) mice) or gamma interferon genes (IFN-gamma(-/-) mice) along with wild-type C57BL/6 mice were immunized intratracheally against P. carinii, depleted of T cells in vivo by use of monoclonal antibodies, and rechallenged intratracheally with 10(7) viable P. carinii organisms. Nearly all immunized mice resolved their lung P. carinii infections (limit of detection, log10 4.06) within 21 days of challenge even though they were depleted of T cells. Unimmunized mice depleted of T cells had significant lung infections (>log10 5.5) at day 21 post-P. carinii challenge. IFN-gamma(-/-) and wild-type mice developed P. carinii-specific immunoglobulin primarily of the immunoglobulin G1 (IgG1) subclass with relatively little P. carinii-specific IgG2a, IgG2b, or IgG3 in their sera, characteristic of a Th2-type response. In contrast, IL-4(-/-) mice had primarily an IgG2b P. carinii-specific antibody response in their sera with very little IgG1. Although IgG2b was the predominant isotype in IL-4(-/-) mice, optical density values of IgG2a and IgG3 were significantly higher in these mice (two and three times, respectively) than in IFN-gamma(-/-) mice, characteristic of a Th1-type response. Together, these data indicate that resolution of P. carinii infection can be mediated by specific antibody responses and that the antibody response can be either a predominantly Th1 or Th2 type. Furthermore, although wild-type mice mounted a Th2-like antibody response, IL-4(-/-) mice could resolve P. carinii pneumonia, indicating that resistance to P. carinii can occur in the absence of IL-4.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393795      PMCID: PMC175728          DOI: 10.1128/iai.65.12.5052-5056.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide.

Authors:  J E Sanford; D M Lupan; A M Schlageter; T R Kozel
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

2.  Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection.

Authors:  W Chen; E A Havell; A G Harmsen
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

3.  Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice.

Authors:  J B Roths; C L Sidman
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

4.  Serologic responses to Pneumocystis carinii antigens in health and disease.

Authors:  S L Peglow; A G Smulian; M J Linke; C L Pogue; S Nurre; J Crisler; J Phair; J W Gold; D Armstrong; P D Walzer
Journal:  J Infect Dis       Date:  1990-02       Impact factor: 5.226

5.  Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection.

Authors:  J R Baldridge; M J Buchmeier
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

6.  Immune response in mice that lack the interferon-gamma receptor.

Authors:  S Huang; W Hendriks; A Althage; S Hemmi; H Bluethmann; R Kamijo; J Vilcek; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

7.  Development and resolution of Pneumocystis carinii pneumonia in severe combined immunodeficient mice: a morphological study of host inflammatory responses.

Authors:  W Chen; J W Mills; A G Harmsen
Journal:  Int J Exp Pathol       Date:  1992-12       Impact factor: 1.925

8.  Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice.

Authors:  A G Harmsen; M Stankiewicz
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

9.  Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1.

Authors:  E S Vitetta; J Ohara; C D Myers; J E Layton; P H Krammer; W E Paul
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

10.  Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens.

Authors:  C M Snapper; T M McIntyre; R Mandler; L M Pecanha; F D Finkelman; A Lees; J J Mond
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

View more
  49 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Oral Immunization of Mice with Live Pneumocystis murina Protects against Pneumocystis Pneumonia.

Authors:  Derrick R Samuelson; Nicholas M de la Rua; Tysheena P Charles; Sanbao Ruan; Christopher M Taylor; Eugene E Blanchard; Meng Luo; Alistair J Ramsay; Judd E Shellito; David A Welsh
Journal:  J Immunol       Date:  2016-02-10       Impact factor: 5.422

Review 3.  The role of Th17 cytokines in primary mucosal immunity.

Authors:  Jay K Kolls; Shabaana A Khader
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-20       Impact factor: 7.638

4.  STAT4-dependent and -independent Th2 responses correlate with protective immunity against lung infection with Pneumocystis murina.

Authors:  Riley C Myers; Chad W Dunaway; Michael P Nelson; Jennifer L Trevor; Alison Morris; Chad Steele
Journal:  J Immunol       Date:  2013-05-06       Impact factor: 5.422

Review 5.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

Review 6.  Helper T-cell type 17 cytokines and immunity in the lung.

Authors:  Jay K Kolls
Journal:  Ann Am Thorac Soc       Date:  2014-12

7.  B Lymphocytes Are Required during the Early Priming of CD4+ T Cells for Clearance of Pneumocystis Infection in Mice.

Authors:  Michael M Opata; Melissa L Hollifield; Frances E Lund; Troy D Randall; Robert Dunn; Beth A Garvy; David J Feola
Journal:  J Immunol       Date:  2015-06-03       Impact factor: 5.422

8.  The Trophic Life Cycle Stage of the Opportunistic Fungal Pathogen Pneumocystis murina Hinders the Ability of Dendritic Cells To Stimulate CD4+ T Cell Responses.

Authors:  Heather M Evans; Andrew Simpson; Shu Shen; Arnold J Stromberg; Carol L Pickett; Beth A Garvy
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

9.  Pulmonary Interleukin-17-Positive Lymphocytes Increase during Pneumocystis murina Infection but Are Not Required for Clearance of Pneumocystis.

Authors:  Chiara Ripamonti; Lisa R Bishop; Joseph A Kovacs
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

10.  The life cycle stages of Pneumocystis murina have opposing effects on the immune response to this opportunistic, fungal pathogen.

Authors:  Heather M Evans; Grady L Bryant; Beth A Garvy
Journal:  Infect Immun       Date:  2016-08-29       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.